USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -274.29 Thousand USD | 20.14% |
2022 | -343.45 Thousand USD | -122.37% |
2021 | 24.76 Thousand USD | 85.25% |
2020 | -1.04 Million USD | 21.27% |
2019 | -1.3 Million USD | 34.57% |
2018 | -2 Million USD | -49.73% |
2017 | -1.29 Million USD | 2.79% |
2016 | -1.34 Million USD | 21.32% |
2015 | -1.64 Million USD | 5.71% |
2014 | -1.88 Million USD | -0.15% |
2013 | -1.88 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 FY | - USD | 20.14% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 100.0% |
2023 Q1 | -97.77 Thousand USD | 19.13% |
2022 Q2 | -77.69 Thousand USD | -188.23% |
2022 Q3 | -232.9 Thousand USD | -199.78% |
2022 FY | - USD | -122.37% |
2022 Q4 | -120.9 Thousand USD | 48.09% |
2022 Q1 | 88.05 Thousand USD | 296.02% |
2021 Q3 | -9360.00 USD | 68.59% |
2021 Q2 | -29.8 Thousand USD | 57.65% |
2021 Q1 | -70.37 Thousand USD | 63.85% |
2021 FY | - USD | 85.25% |
2021 Q4 | -44.92 Thousand USD | -379.91% |
2020 Q3 | -263.9 Thousand USD | -3.56% |
2020 Q2 | -254.82 Thousand USD | 20.02% |
2020 Q1 | -318.59 Thousand USD | -73.29% |
2020 FY | - USD | 21.27% |
2020 Q4 | -194.63 Thousand USD | 26.25% |
2019 Q3 | -607.18 Thousand USD | -206.83% |
2019 Q1 | -316.29 Thousand USD | 55.33% |
2019 Q4 | -183.85 Thousand USD | 69.72% |
2019 FY | - USD | 34.57% |
2019 Q2 | -197.89 Thousand USD | 37.44% |
2018 FY | - USD | -49.73% |
2018 Q4 | -708.02 Thousand USD | -49.41% |
2018 Q3 | -473.87 Thousand USD | 12.06% |
2018 Q2 | -538.88 Thousand USD | -87.75% |
2018 Q1 | -287.02 Thousand USD | 24.95% |
2017 Q3 | -96.37 Thousand USD | 79.74% |
2017 Q1 | -340.07 Thousand USD | -28.83% |
2017 Q2 | -475.58 Thousand USD | -39.85% |
2017 Q4 | -382.46 Thousand USD | -296.87% |
2017 FY | - USD | 2.79% |
2016 Q1 | -254.74 Thousand USD | -20.17% |
2016 FY | - USD | 21.32% |
2016 Q4 | -263.96 Thousand USD | 38.23% |
2016 Q3 | -427.35 Thousand USD | -83.75% |
2016 Q2 | -232.57 Thousand USD | 8.7% |
2015 Q2 | -469.64 Thousand USD | 1.47% |
2015 Q3 | -486.66 Thousand USD | -3.62% |
2015 Q4 | -211.99 Thousand USD | 56.44% |
2015 FY | - USD | 5.71% |
2015 Q1 | -476.65 Thousand USD | -31.6% |
2014 Q4 | -362.18 Thousand USD | 26.5% |
2014 Q3 | -492.76 Thousand USD | 16.77% |
2014 Q1 | -436.07 Thousand USD | -26.14% |
2014 Q2 | -592.01 Thousand USD | -35.76% |
2014 FY | - USD | -0.15% |
2013 Q2 | -723.73 Thousand USD | 0.0% |
2013 Q3 | -531.92 Thousand USD | 26.5% |
2013 Q4 | -345.69 Thousand USD | 35.01% |
2013 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CVR Medical Corp. | - USD | Infinity% |
IR-Med Inc. | -4.89 Million USD | 94.393% |
Polarean Imaging plc | -11.19 Million USD | 97.55% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 160.143% |
Avitar, Inc. | -1.66 Million USD | 83.554% |
AVITA Medical, Inc. | -39.56 Million USD | 99.307% |
Manhattan Scientifics, Inc. | -1.16 Million USD | 76.436% |
Össur hf. | 137.38 Million USD | 100.2% |
Zecotek Photonics Inc. | -3.44 Million USD | 92.032% |
QHSLab, Inc. | -91.29 Thousand USD | -200.45% |
Wellstar International, Inc. | -1.35 Million USD | 79.78% |
Össur hf. | 137.38 Million USD | 100.2% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 102.806% |
Escalon Medical Corp. | -58.46 Thousand USD | -369.185% |
Aurora Spine Corporation | -454.37 Thousand USD | 39.634% |
BrainsWay Ltd. | -2.31 Million USD | 88.131% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | -9.37 Million USD | 97.076% |
Hamilton Thorne Ltd. | 5.52 Million USD | 104.968% |
Vivos Inc. | -2.79 Million USD | 90.18% |
MicroPort Scientific Corporation | -347.57 Million USD | 99.921% |
Kelyniam Global, Inc. | -197.69 Thousand USD | -38.747% |
REMSleep Holdings, Inc. | -1.66 Million USD | 83.561% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | 27.61% |
Nanomix Corporation | -8.13 Million USD | 96.63% |
Theraclion SA | -2.05 Million USD | 86.625% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Wellness Center USA, Inc. | -707.03 Thousand USD | 61.205% |
Positron Corporation | -1.45 Million USD | 81.111% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | 84.07% |
Lombard Medical, Inc. | -28.06 Million USD | 99.023% |
ALR Technologies Inc. | -6.4 Million USD | 95.714% |
Stratec SE | 39.91 Million USD | 100.687% |
Vycor Medical, Inc. | 100.94 Thousand USD | 371.728% |
Heart Tronics, Inc. | -14.85 Million USD | 98.154% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | -131.94% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 97.934% |
SANUWAVE Health, Inc. | -9.15 Million USD | 97.003% |
VMS Rehab Systems, Inc. | -68.55 USD | -400031.291% |
Guided Therapeutics, Inc. | -3.12 Million USD | 91.226% |
Ingen Technologies, Inc. | -8639.00 USD | -3075.02% |
Odyssey Group International, Inc. | -2.13 Million USD | 87.171% |
United American Healthcare Corporation | -59 Thousand USD | -364.898% |
ECGI Holdings, Inc. | -2.99 Million USD | 90.828% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | 56.405% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 46.639% |
Urologix, Inc. | -6.34 Million USD | 95.676% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 77.868% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | 64.19% |
SS Innovations International, Inc. | -20.37 Million USD | 98.654% |
Qualis Innovations, Inc. | -222.81 Thousand USD | -23.1% |
Smith & Nephew plc | 1 Billion USD | 100.027% |
NIOX Group Plc | 11.07 Million USD | 102.477% |
Fuse Medical, Inc. | 1.83 Million USD | 114.945% |
Broncus Holding Corporation | -25.19 Million USD | 98.911% |
Brain Scientific Inc. | -7.93 Million USD | 96.543% |
Pressure BioSciences, Inc. | -9.39 Million USD | 97.079% |
Health Logic Interactive Inc. | -18.4 Thousand USD | -1390.707% |